Paycom Software Inc vs Twist Bioscience Corp — how do they compare? Paycom Software Inc trades at $139 (market cap $6.72B), while Twist Bioscience Corp trades at $93.82 (market cap $5.97B). The key difference: Paycom Software Inc and Twist Bioscience Corp are close in size by market cap, and Paycom Software Inc pays a 1.04% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| PAYC | TWST | |
|---|---|---|
Market Cap | $6.72B | $5.97B |
Sector | Technology | Health |
52-Week High | $238.80 | $102.88 |
52-Week Low | $113.59 | $24.16 |
Enterprise Value | $7.33B | $5.89B |
Dividend Yield | 1.04% | — |
Trailing returns across standard periods
Latest headlines on both assets
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →